Characteristics of ER-positive breast cancer patients (n = 290) and their primary tumors
. | No. patients (%) . | |
---|---|---|
Age (y) | ||
<50 | 74 (25) | |
≥50 | 216 (75) | |
Tumor size (cm) | ||
<2 | 109 (38) | |
2-5 | 134 (46) | |
>5 | 26 (9) | |
Unknown | 21 (7) | |
Histologic grade | ||
1 | 40 (14) | |
2 | 176 (61) | |
3 | 62 (21) | |
Unknown | 11 (4) | |
Lymph node status | ||
Negative | 87 (30) | |
Positive | 139 (48) | |
Unknown | 64 (22) | |
PR | ||
Negative | 83 (29) | |
Positive | 207 (71) | |
HER2/c-erbB2 | ||
Negative | 225 (77) | |
Positive | 57 (20) | |
Not determined | 8 (3) | |
P-MAPK (Thr202/Tyr204) | ||
Negative | 90 (31) | |
Positive | 200 (69) | |
P-AKT (Ser473) | ||
Negative | 84 (29) | |
Positive | 190 (66) | |
Not determined | 16 (5) | |
P-p90RSK (Thr359/Ser363) | ||
Negative | 40 (14) | |
Positive | 234 (81) | |
Not determined | 16 (5) | |
P-S118 | ||
Negative | 50 (17) | |
Positive | 240 (77) | |
P-S167 | ||
Negative | 56 (19) | |
Positive | 229 (79) | |
Not determined | 5 (2) |
. | No. patients (%) . | |
---|---|---|
Age (y) | ||
<50 | 74 (25) | |
≥50 | 216 (75) | |
Tumor size (cm) | ||
<2 | 109 (38) | |
2-5 | 134 (46) | |
>5 | 26 (9) | |
Unknown | 21 (7) | |
Histologic grade | ||
1 | 40 (14) | |
2 | 176 (61) | |
3 | 62 (21) | |
Unknown | 11 (4) | |
Lymph node status | ||
Negative | 87 (30) | |
Positive | 139 (48) | |
Unknown | 64 (22) | |
PR | ||
Negative | 83 (29) | |
Positive | 207 (71) | |
HER2/c-erbB2 | ||
Negative | 225 (77) | |
Positive | 57 (20) | |
Not determined | 8 (3) | |
P-MAPK (Thr202/Tyr204) | ||
Negative | 90 (31) | |
Positive | 200 (69) | |
P-AKT (Ser473) | ||
Negative | 84 (29) | |
Positive | 190 (66) | |
Not determined | 16 (5) | |
P-p90RSK (Thr359/Ser363) | ||
Negative | 40 (14) | |
Positive | 234 (81) | |
Not determined | 16 (5) | |
P-S118 | ||
Negative | 50 (17) | |
Positive | 240 (77) | |
P-S167 | ||
Negative | 56 (19) | |
Positive | 229 (79) | |
Not determined | 5 (2) |